반응식
[NH2:1][CH:2]1[CH2:8][CH2:7][CH2:6][CH2:5][N:4]([CH2:9][C:10]2[CH:15]=[CH:14][C:13]([Cl:16])=[CH:12][CH:11]=2)[CH2:3]1.[C:17]([CH2:25][CH2:26][CH2:27][C:28](O)=[O:29])(=[O:24])[C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1.CCN=C=NCCCN(C)C.C1C=CC2N(O)N=NC=2C=1>C(Cl)(Cl)Cl.C(Cl)Cl.CCN(CC)CC>[Cl:16][C:13]1[CH:12]=[CH:11][C:10]([CH2:9][N:4]2[CH2:5][CH2:6][CH2:7][CH2:8][CH:2]([NH:1][C:28](=[O:29])[CH2:27][CH2:26][CH2:25][C:17](=[O:24])[C:18]3[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=3)[CH2:3]2)=[CH:15][CH:14]=1참가 물질
8
반응물 4
생성물 1
시약·촉매·용매 3
반응 조건
- 온도
- 25 °C
실험 절차
A solution of 3-amino-1-(4-chlorobenzyl)homopiperidine (24 mg, 0.10 mmol) and 4-benzoylbutyric acid (1.2 equiv.) in CHCl3 (1 mL) was treated with EDCI (23 mg), HOBt (16.2 mg) and Et3N (15.2 μL), and stirred at 25° C. for 16 h. The reaction mixture was diluted with CH2Cl2 (0.5 mL), washed with 2 N aqueous NaOH solution (2×0.75 mL), dried by filtration through a PTFE membrane and concentrated to afford 1-(4-chlorobenzyl)-3-{(4-benzoylbutyryl)amino}homopiperidine (compound No. 994) (43 mg, 99%): The purity was determined by RPLC/MS (98%); ESI/MS m/e 413 (M++H, C24H28ClN2O2).
후처리
- washwashed with 2 N aqueous NaOH solution (2×0.75 mL)
- dry with materialdried by filtration through a PTFE membrane
- concentrationconcentrated
출처 및 근거
- ORD 기록
- ord-85b4bc3dfe654ed39083f3c9e097061e
- 출처 데이터셋
- uspto-grants-2002_09
- 특허 번호
- US06451842B1
연결된 노트
불러오는 중…